Product Information
CARVEDILOL ER 40 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $6.3787 per EA under NDC 57664066583. Its NADAC has been published 450 times since Feb 21, 2018.
FDA first approved this application on Oct 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664066583
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARVEDILOL PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA090132FDA Approved
10/25/2017
TE Code
AB
On Market Since
11/8/2017
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL ER 40 MG CAPSULE has been published 450 times since Feb 21, 2018, and over the history we have for it it has declined 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3787 per EA |
|---|---|
| All-time high | $7.0845 (Jan 16, 2019) |
| All-time low | $4.0723 (Nov 20, 2024) |
| 52-week high | $6.6829 |
| 52-week low | $5.5853 |
| Median price | $5.8758 |
| Average price | $5.8646 |
| Largest weekly change | -29.1% (Nov 20, 2024) |
| Weeks tracked | 450 |
| Tracking since | Feb 21, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carvedilol Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARVEDILOL ER 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL ER 40 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $6.3787 per EA (NDC 57664066583), effective Sep 30, 2026.
How has the price of CARVEDILOL ER 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CARVEDILOL ER 40 MG CAPSULE has declined 3.3%. It has been tracked across 450 weekly CMS publications since Feb 21, 2018.
What are the highest and lowest recorded NADAC prices for CARVEDILOL ER 40 MG CAPSULE?
Since Feb 21, 2018, the NADAC for CARVEDILOL ER 40 MG CAPSULE has ranged from a low of $4.0723 (Nov 20, 2024) to a high of $7.0845 (Jan 16, 2019), with a median of $5.8758 per EA.
Are there cheaper alternatives to CARVEDILOL ER 40 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARVEDILOL ER 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CARVEDILOL ER 40 MG CAPSULE?
CARVEDILOL ER 40 MG CAPSULE (NDC 57664066583) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.